1 / 6

Filgrastim Biosimilars Market Landscapes, Opportunities, Demand And Covid-19 Update

The latest trending report of TBRC is Filgrastim Biosimilars Market 2020, offers comprehensive research on major players, regions and segments. https://bit.ly/2FRc0mF

JayanthiTBRC
Télécharger la présentation

Filgrastim Biosimilars Market Landscapes, Opportunities, Demand And Covid-19 Update

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Global Filgrastim FilgrastimBiosimilars Growth Growth, , Opportunities, Strategies And Forecast To 2023 Opportunities, Strategies And Forecast To 2023 Biosimilars Market (Covid Market (Covid- -19) 19) Analysis Analysis, , © The Business Research Company. All rights reserved. www.tbrc.info Email: info@tbrc.info

  2. Market Characteristics Characteristics: : Filgrastim FilgrastimBiosimilars Biosimilars Market • The global filgrastim biosimilars market is expected to decline from $511.15 million in 2019 to $445.04 million in 2020 at a compound annual growth rate (CAGR) of - 12.93%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges. The entire supply chain has been disrupted, impacting the filgrastim biosimilar market negatively. The filgrastim biosimilar market is then expected to recover and reach $751.96 billion in 2023 at a CAGR of 19.11%. The report covers the Filgrastim Biosimilars market’s segments- 1) By Application: Oncology, Chronic And Autoimmune Diseases, Blood Disorders, Growth Hormone Deficiency, Infectious Diseases, Others 2) By Distribution Channels: Hospital Pharmacy, Retail Pharmacy, And Online Pharmacy Click Here To View Complete Report 2 © The Business Research Company. All rights reserved.

  3. Major Key Players Major Key Players The major players covered in the global filgrastim biosimilars market are Cadila Pharmaceuticals, Dr. Reddy`s Laboratories, Intas Biopharmaceuticals, Sandoz, Amgen Inc., Dr. Reddy`s Laboratories Ltd, Intas Pharmaceuticals, Emcure Pharmaceuticals Ltd., Biocon, Aryogen Biopharma, Claris Life Sciences, Adello Biologics, Hospira (Pfizer), Gennova Biopharmaceuticals, Teva Pharmaceuticals Industries, F. Hoffmann-La Roche Ltd., Lupin Limited, Abbott Laboratories Inc., Reliance Life Sciences Pvt. Ltd., Novartis AG. Click Here To Get A Sample Report 3 © The Business Research Company. All rights reserved.

  4. Table Of Content Table Of Content 1. Executive Summary 2. Filgrastim Biosimilars Market Characteristics 3. Filgrastim Biosimilars Market Size And Growth 4. Filgrastim Biosimilars Market Segmentation 5. Filgrastim Biosimilars Market Regional And Country Analysis …… 25. Filgrastim Biosimilars Market Competitive Landscape And Company Profiles 26. Key Mergers And Acquisitions In The Filgrastim Biosimilars Market 27. Filgrastim Biosimilars Market Trends And Strategies 28. Filgrastim Biosimilars Market Future Outlook and Potential Analysis 29. Appendix Click Here To Get A Sample Report 4 The Business Research Company. All rights reserved.

  5. Get In Touch Whatever your need be, at The Business Research Company we provide research consulting solutions for businesses, government agencies consultancies, and market research companies. 5 © The Business Research Company. All rights reserved.

  6. Europe Asia Americas The Business Research Company 47 Anchorage Point, 42 Cuba Street, Canary Wharf, London, England, E14 8NE. +44 207 1930 708 Email: info@tbrc.info www.tbrc.info The Business Research Company, Horizon Avenue, 8-2-603/b/s/1/2 Road Number 10 Banjara Hills Hyderabad (India) 500033 ++91 8897263534 Email: info@tbrc.info www.tbrc.info The Business Research Company 625 South Avenue, Apt B204, Secane, Philadelphia, PA 19018, USA +1 3156230293 Email: info@tbrc.info www.tbrc.info 6 © The Business Research Company. All rights reserved.

More Related